Medical device biocompatibility testing is a quality control standard for the development and manufacturing of medical devices. Biocompatibility testing evaluates the effect of a medical device on human tissues to determine whether it can cause biological reactions such as ...Learn More

Proregulations is excited to announce its participation in the 29th CBA Annual Conference, which will be held at the Marriott Washingtonian Center (9751 Washingtonian Blvd, Gaithersburg, MD 20878), on June 9, 2024, 07:45 am - 5:30 pm.About CBAThe Chinese Biopharmaceutical ...Learn More

The 2024 CPHI North America Conference is scheduled to be held at the Pennsylvania Convention Center in Philadelphia, a heavy industrial city in the United States, on May 7-9, 2024 (local time). Proregulations will participate in CPHI North America Conference, and our booth number ...Learn More

Proregulations is about to participate in DCAT Week 2024, scheduled for March 18-21, 2024 (local time) in New York City. During DCAT Week 2024, staff at Proregulations will be in Converted Room #1415, Lotte NY Palace Hotel, 455 Madison Ave, New York, NY 10022. “Welcome to Lotte ...Learn More

Proregulations is a newly emerging regulatory consulting firm that specializes in assisting medical device manufacturers and companies in navigating the complex process of registering their products with the U.S. Food and Drug Administration (FDA). With its comprehensive range of ...Learn More